PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: Half Yearly Report and Accounts, page-18

  1. 5,011 Posts.
    lightbulb Created with Sketch. 654
    Thats a shame for but fair enough.. and agree 100% with ur decision. Exciting time to b in them both that’s for sure.
    good luck mate
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.